Phio Pharmaceuticals Corp (PHIO) Stock Price

2.40 ▼ -0.08 (-3.23%)
Open: 2.49 Vol: 84.05K Day's range: 2.33 - 2.49 Jul 03, 16:00 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
PHIO Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY BUY BUY BUY BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 2.38▲ 2.40▲ 2.40▲ 2.38▲ 2.41▼
MA10 2.42▼ 2.43▼ 2.43▼ 2.29▲ 2.14▲
MA20 2.44▼ 2.45▼ 2.40▲ 2.41▼ 1.86▲
MA50 2.34▲ 2.30▲ 2.27▲ 2.11▲ 2.34▲
MA100 2.27▲ 2.30▲ 2.34▲ 1.84▲ 5.73▼
MA200 2.33▲ 2.41▲ 2.22▲ 2.28▲ 44.55▼
  5 mins 30 mins Hourly Daily Weekly
MACD -0.014▼ -0.018▼ -0.012▼ -0.005▼ 0.138▲
RSI 50.657▲ 52.288▲ 54.666▲ 54.955▲ 52.204▲
STOCH 32.341     33.333     31.250     57.967     48.231    
WILL %R -50.000     -56.250     -56.250     -30.952     -37.202    
CCI -35.897     -77.218     -71.758     71.901     53.541    
Latest Filters Detected On PHIO
CDL $PHIO Engulfing Candlestick Pattern Detected Set Alert
Phio Pharmaceuticals Corp News
Phio Pharmaceuticals Corp. (PHIO)
Tuesday, July 01, 2025 01:00 PM
Marlborough, Massachusetts--(Newsfile Corp. - February 20, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL ...
Phio Pharmaceuticals Announces Positive Safety Monitoring Committee Recommendation to Advance INTASYL PH-762 Skin Cancer Clinical Trial to Fifth Dose Escalation Cohort - Nasdaq
Wednesday, June 25, 2025 04:45 AM
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company advancing its INTASYL® gene silencing technology focused on immuno-oncology therapeutics.
Phio Pharmaceuticals Corp.: Phio Pharmaceuticals Announces Strategic Initiative to Create Awareness of the Comprehensive INTASYL siRNA Portfolio - FinanzNachrichten.de
Friday, June 06, 2025 06:50 AM
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company advancing its INTASYL ® gene silencing technology focused on immuno-oncology therapeutics.
PHIO historical stock data
date open high low close volume
03/07/25 2.49 2.49 2.33 2.40 84,045
02/07/25 2.45 2.48 2.42 2.48 137,818
01/07/25 2.37 2.53 2.3032 2.48 232,450
30/06/25 2.16 2.36 2.16 2.35 168,989
27/06/25 2.25 2.2595 2.15 2.17 97,814
26/06/25 2.27 2.29 2.15 2.21 202,881
25/06/25 2.27 2.3001 2.11 2.17 1,083,063
24/06/25 2.19 2.23 2.1808 2.21 92,313
23/06/25 2.22 2.26 2.16 2.18 121,009
20/06/25 2.36 2.36 2.20 2.265 171,614
Quote Details
52wk Low:0.966
52wk High:9.79
Vol:84.05K
Avg Vol(3m):10.7M
1Y Chng:-46.67%
1M Chng:+34.08%
Add to Watch List
More Information
Index US Composite
Market Cap. 11.52M